During the last session, Tango Therapeutics Inc (NASDAQ:TNGX)’s traded shares were 8.66 million, with the beta value of the company hitting 1.15. At the end of the trading day, the stock’s price was $2.33, reflecting an intraday gain of 20.10% or $0.39. The 52-week high for the TNGX share is $12.02, that puts it down -415.88 from that peak though still a striking 55.79% gain since the share price plummeted to a 52-week low of $1.03. The company’s market capitalization is $252.55M, and the average trade volume was 1.50 million shares over the past three months.
Tango Therapeutics Inc (TNGX) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.12. TNGX has a Sell rating from 0 analyst(s) out of 3 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 3 recommend a Buy rating for it.
Tango Therapeutics Inc (NASDAQ:TNGX) trade information
Tango Therapeutics Inc (TNGX) registered a 20.10% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 20.10% in intraday trading to $2.33, hitting a weekly high. The stock’s 5-day price performance is 23.28%, and it has moved by 71.32% in 30 days. Based on these gigs, the overall price performance for the year is -66.28%.
The consensus price target of analysts on Wall Street is $13, which implies an increase of 82.08% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $13 and $18 respectively. As a result, TNGX is trading at a discount of -672.53% off the target high and -457.94% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 7.47%. While earnings are projected to return -14.29% in 2025, the next five years will return -5.61% per annum.
TNGX Dividends
Tango Therapeutics Inc is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Tango Therapeutics Inc (NASDAQ:TNGX)’s Major holders
The next largest institutional holding, with 13.33 million shares, is of ECOR1 CAPITAL, LLC’s that is approximately 12.3075% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $114.38 million.
Also, the Mutual Funds coming in first place with the largest holdings of Tango Therapeutics Inc (TNGX) shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and T. Rowe Price Small-Cap Value Fund, Inc. Data provided on Mar 31, 2025 indicates that VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund owns about 2.2 shares. This amounts to just over 2.03 percent of the company’s overall shares, with a $5.14 million market value. The same data shows that the other fund manager holds slightly less at 1.66, or about 1.54% of the stock, which is worth about $3.88 million.
